Roadmap and Considerations for Genome Editing in a Non-Model Organism: Genetic Variations and Off-Target Profiling

被引:1
|
作者
Wattad, Hanin [1 ]
Molcho, Jonathan [1 ]
Manor, Rivka [1 ,2 ]
Weil, Simy [1 ]
Aflalo, Eliahu D. [1 ,3 ]
Chalifa-Caspi, Vered [4 ]
Sagi, Amir [1 ,2 ]
机构
[1] Ben Gurion Univ Negev, Dept Life Sci, POB 653, IL-8410501 Beer Sheva, Israel
[2] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, POB 653, IL-8410501 Beer Sheva, Israel
[3] Achva Acad Coll, Dept Life Sci, IL-7980400 Arugot, Israel
[4] Ben Gurion Univ Negev, Ilse Katz Inst Nanoscale Sci & Technol, Bioinformat Core Facil, IL-8410501 Beer Sheva, Israel
关键词
CRISPR/Cas; GUIDE-seq; <italic>Macrobrachium rosenbergii</italic>; sex chromosomes; single nucleotide polymorphisms (SNPs); repetitive sequences; MUTAGENESIS; CRISPR; EVOLUTION; MAKER; TOOL; SNP;
D O I
10.3390/ijms252312530
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The CRISPR/Cas genome editing approach in non-model organisms poses challenges that remain to be resolved. Here, we demonstrated a generalized roadmap for a de novo genome annotation approach applied to the non-model organism Macrobrachium rosenbergii. We also addressed the typical genome editing challenges arising from genetic variations, such as a high frequency of single nucleotide polymorphisms, differences in sex chromosomes, and repetitive sequences that can lead to off-target events. For the genome editing of M. rosenbergii, our laboratory recently adapted the CRISPR/Cas genome editing approach to embryos and the embryonic primary cell culture. In this continuation study, an annotation pipeline was trained to predict the gene models by leveraging the available genomic, transcriptomic, and proteomic data, and enabling accurate gene prediction and guide design for knock-outs. A next-generation sequencing analysis demonstrated a high frequency of genetic variations in genes on both autosomal and sex chromosomes, which have been shown to affect the accuracy of editing analyses. To enable future applications based on the CRISPR/Cas tool in non-model organisms, we also verified the reliability of editing efficiency and tracked off-target frequencies. Despite the lack of comprehensive information on non-model organisms, this study provides an example of the feasibility of selecting and editing specific genes with a high degree of certainty.
引用
收藏
页数:21
相关论文
共 50 条
  • [31] Human Genetic Diversity Alters Therapeutic Gene Editing Off-Target Outcomes
    Lin, Linda Yingqi
    Cancellieri, Samuele
    Zeng, Jing
    Masillo, Francesco
    Nguyen, My Anh
    Bombieri, Nicola
    Maitland, Stacy A.
    Ciuculescu, Marioara-Felicia
    Katta, Varun
    Tsai, Shengdar Q.
    Armant, Myriam
    Wolfe, Scot A.
    Giugno, Rosalba
    Pinello, Luca
    Bauer, Daniel E.
    BLOOD, 2021, 138
  • [32] Human genetic diversity alters off-target outcomes of therapeutic gene editing
    Cancellieri, Samuele
    Zeng, Jing
    Lin, Linda Yingqi
    Tognon, Manuel
    Nguyen, My Anh
    Lin, Jiecong
    Bombieri, Nicola
    Maitland, Stacy A.
    Ciuculescu, Marioara-Felicia
    Katta, Varun
    Tsai, Shengdar Q.
    Armant, Myriam
    Wolfe, Scot A.
    Giugno, Rosalba
    Bauer, Daniel E.
    Pinello, Luca
    NATURE GENETICS, 2023, 55 (01) : 34 - +
  • [33] Human genetic diversity alters off-target outcomes of therapeutic gene editing
    Samuele Cancellieri
    Jing Zeng
    Linda Yingqi Lin
    Manuel Tognon
    My Anh Nguyen
    Jiecong Lin
    Nicola Bombieri
    Stacy A. Maitland
    Marioara-Felicia Ciuculescu
    Varun Katta
    Shengdar Q. Tsai
    Myriam Armant
    Scot A. Wolfe
    Rosalba Giugno
    Daniel E. Bauer
    Luca Pinello
    Nature Genetics, 2023, 55 : 34 - 43
  • [34] Nuclease Target Site Selection for Maximizing On-target Activity and Minimizing Off-target Effects in Genome Editing
    Lee, Ciaran M.
    Cradick, Thomas J.
    Fine, Eli J.
    Bao, Gang
    MOLECULAR THERAPY, 2016, 24 (03) : 475 - 487
  • [35] Occurrence and Nature of Off-Target Modifications by CRISPR-Cas Genome Editing in Plants
    Sturme, Mark H. J.
    van der Berg, Jan Pieter
    Bouwman, Lianne M. S.
    De Schrijver, Adinda
    de Maagd, Ruud A.
    Kleter, Gijs A.
    Battaglia-de Wilde, Evy
    ACS AGRICULTURAL SCIENCE & TECHNOLOGY, 2022, 2 (02): : 192 - 201
  • [36] GOTI, a method to identify genome-wide off-target effects of genome editing in mouse embryos
    Zuo, Erwei
    Sun, Yidi
    Wei, Wu
    Yuan, Tanglong
    Ying, Wenqin
    Sun, Hao
    Yuan, Liyun
    Steinmetz, Lars M.
    Li, Yixue
    Yang, Hui
    NATURE PROTOCOLS, 2020, 15 (09) : 3009 - 3029
  • [37] Off-target genome editing: A new discipline of gene science and a new class of medicine
    Diane Catherine Wang
    Xiangdong Wang
    Cell Biology and Toxicology, 2019, 35 : 179 - 183
  • [38] Large Serine Integrase Off-Target Discovery and Validation for Therapeutic Human Genome Editing
    Hazelbaker, Dane Z.
    Mehta, Japan B.
    Santesmasses, Didac
    McGinnis, Connor
    Biondi, Thomas
    Bara, Anne M.
    Liang, Xiaoyu
    Estes, Brett
    Xie, Jenny
    Molugu, Kaivalya
    Amunugama, Ravindra
    Luo, Chong
    Cochrane, Jesse
    Kumar, Sandeep
    Bakalar, Matthew H.
    Wang, Jie
    O'Connell, Daniel J.
    Finn, Jonathan D.
    MOLECULAR THERAPY, 2024, 32 (04) : 104 - 105
  • [39] In vivo CRISPR gene editing with no detectable genome-wide off-target mutations
    Akcakaya, P.
    Bobbin, M. L.
    Guo, J. A.
    Malagon-Lopez, J.
    Clement, K.
    Garcia, S. P.
    Fellows, M. D.
    Porritt, M. J.
    Firth, M. A.
    Carreras, A.
    Baccega, T.
    Seeliger, F.
    Bjursell, M.
    Tsai, S. Q.
    Nguyen, N. T.
    Nitsch, R.
    Mayr, L. M.
    Pinello, L.
    Bohlooly-Y, M.
    Aryee, M.
    Maresca, M.
    Joung, J. K.
    HUMAN GENE THERAPY, 2018, 29 (12) : A15 - A15
  • [40] GOTI, a method to identify genome-wide off-target effects of genome editing in mouse embryos
    Erwei Zuo
    Yidi Sun
    Wu Wei
    Tanglong Yuan
    Wenqin Ying
    Hao Sun
    Liyun Yuan
    Lars M. Steinmetz
    Yixue Li
    Hui Yang
    Nature Protocols, 2020, 15 : 3009 - 3029